Shares of AbbVie, Eli Lilly and Johnson & Johnson were on track to hit all-time highs Friday, in the latest signal that investor appetite for the biopharmaceutical sector is back.
Source link
Trending
- BYD’s pickup spotted in China with a different look
- FDA Approves First Generic Rifapentine for Active and Latent Tuberculosis
- These are the best deals you can still get on MacBooks before Apple’s price hike kicks in
- OpenAI limits GPT-5.6 rollout after government request, says restrictions shouldn’t be the norm
- Goldman Sachs raises India FY27 growth forecast to 6.5%
- ET Graphics: From budget to premium, gadget Prices Rise
- The World Cup has made Cape Verde goalkeeper Vozinha a $17 million star
- El Nino may force India to boost rice-based ethanol output for E20 goal
